Drugs / umbilical cord blood mesenchymal stem cells
umbilical cord blood mesenchymal stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02812121 | Jun 2016 → Jun 2017 | liver failure | Sun Yat-sen University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | umbilical cord blood mesenchymal stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02812121 ↗ |
| Modality | Cell therapy | “umbilical cord blood mesenchymal stem cells” NCT02812121 ↗ |
| Route | Intravenous | “via peripheral veins” NCT02812121 ↗ |